Send to

Choose Destination
Obstet Gynecol. 2015 Jun;125(6):1330-7. doi: 10.1097/AOG.0000000000000874.

Cell-free DNA analysis in maternal plasma in cases of fetal abnormalities detected on ultrasound examination.

Author information

Service de Gynécologie-Obstétrique et Médecine de la Reproduction, Hôpital Antoine Béclère, Clamart, France; Université Paris Sud, Paris, France; Laboratoire CERBA, Saint-Ouen l'Aumône, France; Gynécologie-Obstétrique, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Centre de Diagnostic Prénatal, Hôpital Américain de Paris, Neuilly-sur-Seine, France; Gynécologie-Obstétrique, SIHCUS-CMCO, Schiltigheim, France; Gynécologie-Obstétrique, Centre Hospitalier René Dubos, Pontoise, France; Centre de Diagnostic Prénatal, Centre Hospitalier Régional Universitaire, Lille, France; and Inserm, Le Kremlin-Bicêtre, France.



To evaluate the utility of noninvasive prenatal testing using cell-free circulating fetal DNA for detection of the three main autosomal fetal trisomies in the setting of ultrasonographically identified fetal anomalies.


Nine hundred patients at risk for fetal aneuploidy with or without ultrasonography anomalies and who underwent invasive procedures were included in the study. Cell-free DNA analysis was performed by massive parallel sequencing during a multicenter, noninterventional, prospective study and the results were compared with a fetal karyotype.


Among all 900 pregnancies, cell-free DNA identified 76 of 76 (100%) fetal Down syndrome, 22 of 25 (88%) trisomy 18, and 12 of 12 (100%) trisomy 13. In those with a normal ultrasonogram and normal cell-free DNA analysis, karyotype identified 2 of 483 (0.4%) additional aneuploidies other than trisomies 13, 18, and 21. In those with an abnormal ultrasonogram and a normal cell-free DNA analysis, there were 23 of 290 (7.9%) additional pathogenic karyotypes. These additional aneuploidies included sex chromosome abnormalities and triploidy. The rates of additional aneuploidies not identifiable by standard cell-free DNA screening in the two groups is significantly different at P<.01.


In women with fetal abnormalities by ultrasonography, the rate of pathogenic chromosome abnormalities missed by cell-free DNA was 8%. Noninvasive prenatal testing should not be offered to women with fetal abnormalities because a negative result is falsely reassuring.



[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center